Proteomic analysis of differentially expressed proteins in 5-fluorouracil-treated human breast cancer MCF-7 cells
Authors:
- 12 November 2013
- journal article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 16 (7) , 650-659
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Fascin-1 is a novel biomarker of aggressiveness in some carcinomasBMC Medicine, 2013
- Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysisBMC Medicine, 2013
- Quercetin enhances the effects of 5-fluorouracil-mediated growth inhibition and apoptosis of esophageal cancer cells by inhibiting NF-κBOncology Letters, 2012
- A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancerClinical and Translational Oncology, 2012
- Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinomaJournal of Clinical Investigation, 2012
- Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cellsJournal of Cell Science, 2012
- Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomasLung Cancer, 2010
- The role of enoyl‐CoA hydratase short chain 1 and peroxiredoxin 3 in PP2‐induced apoptosis in human breast cancer MCF‐7 cellsFEBS Letters, 2010
- c-myc Promoter-binding Protein 1 (MBP-1) Regulates Prostate Cancer Cell Growth by Inhibiting MAPK PathwayJournal of Biological Chemistry, 2005
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957